{'fraction_non_alphanumeric': 0.02097902097902098, 'fraction_numerical': 0.02097902097902098, 'mean_word_length': 5.155913978494624, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Expanded use of internal mammary artery graft for myocardial revascularization.

To improve the early and late benefits of coronary artery bypass grafting, use of internal mammary artery grafts was expanded. The first 60 patients to receive two mammary artery-coronary artery anastomoses and supplemental saphenous vein grafts are reviewed. Altogether 210 grafts (3.5/patient) were performed, including 54 mammary artery grafts in situ, six of them as free grafts. In 12 patients the right internal mammary artery was placed through the transverse sinus to revascularize the circumflex artery, and the left mammary artery was placed to the left anterior descending artery. In the remaining 48 patients both internal mammary arteries were used to revascularize the left anterior descending and the right coronary artery. There were no perioperative deaths and no sternal infections. Postoperative complications included re-exploration for bleeding and diaphragmatic dysfunction. Late follow-up was complete. Of 60 patients observed for 1/2 to 4 years, 57 were asymptomatic. Exercise stress tests were performed in 58 cases and were normal in 56.